Jazz Pharmaceuticals Stock Forecast

Stock Price Forecast

The 15 analysts with 12-month price forecasts for Jazz Pharmaceuticals stock have an average target of 194.4, with a low estimate of 147 and a high estimate of 247. The average target predicts an increase of 14.56% from the current stock price of 169.70.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$147	$194.4	$200	$247
Change	-13.38%	+14.56%	+17.86%	+45.55%

Analyst Ratings

The average analyst rating for Jazz Pharmaceuticals stock from 15 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	4	5	5	5	5	5
Buy	7	8	8	8	8	8
Hold	1	1	1	1	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	14	14	14	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ashwani Verma UBS	UBS	Strong Buy → Hold Downgrades $163 → $188	Strong Buy → Hold	Downgrades	$163 → $188	+10.78%	Nov 24, 2025
Mohit Bansal Wells Fargo	Wells Fargo	Buy Maintains $170 → $235	Buy	Maintains	$170 → $235	+38.48%	Nov 18, 2025
Joel Beatty Baird	Baird	Buy Maintains $160 → $209	Buy	Maintains	$160 → $209	+23.16%	Nov 18, 2025
Jason Gerberry B of A Securities	B of A Securities	Strong Buy Maintains $230 → $247	Strong Buy	Maintains	$230 → $247	+45.55%	Nov 18, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Buy Maintains $185 → $205	Buy	Maintains	$185 → $205	+20.80%	Nov 17, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

4.31B

from 4.07B

6.00%

from 4.07B

Revenue Next Year

4.61B

from 4.31B

6.84%

from 4.31B

EPS This Year

8.24

from 8.65

-4.76%

from 8.65

EPS Next Year

23.12

from 8.24

180.63%

from 8.24

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.36B	3.09B	3.66B	3.83B	4.07B	4.31B	4.61B
Revenue Growth	9.34%	30.91%	18.26%	4.78%	6.12%	6.00%	6.84%
EPS	4.22	-5.52	-3.58	6.10	8.65	8.24	23.12
EPS Growth	-53.58%	-	-	-	41.75%	-4.76%	180.63%
Forward PE	-	-	-	-	-	20.60	7.34
No. Analysts	-	-	-	-	-	21	21

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	4.5B	5.2B
Avg	4.3B	4.6B
Low	4.1B	4.0B

Revenue Growth

Revenue Growth	2025	2026
High	10.3%	21.2%
Avg	6.0%	6.8%
Low	0.8%	-6.4%

EPS Forecast

EPS	2025	2026
High	8.86	31.55
Avg	8.24	23.12
Low	7.56	19.52

EPS Growth

EPS Growth	2025	2026
High	2.5%	283.0%
Avg	-4.8%	180.6%
Low	-12.6%	137.0%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.